A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
A Randomized Double-blind, Placebo-controlled, Parallel-group, Multicenter, Phase 3 Study to Evaluate the Long-term Safety of Naldemedine for the Treatment of Opioid-induced Constipation in Subjects With Non-malignant Chronic Pain Receiving Opioid Therapy
The purpose of this study is to evaluate the long-term safety of naldemedine for the treatment of constipation due to opioid therapy.
Inclusion Criteria
Exclusion Criteria
Pribram V- Zdabor, Czechia
Soulaine Sur Aubance, France
Lyttelton Centurion, South Africa
Muckleneuk Pretoria, South Africa
Pretoria West Pretoria, South Africa
Bexhill on Sea East Sussex, United Kingdom
Chestfield Kent, United Kingdom
Daventry Northants, United Kingdom
Devon, United Kingdom
Epworth Doncaster, United Kingdom
Spiro Close, Pulborough West Sussex, United Kingdom
Wellingborough Northamptonshire, United Kingdom